Term ends Mar 11, 2034 · High confidence
20-year base term ends Mar 11, 2034
Held by Biolase MG LLC
Filed Aug 17, 2021 as application 17/404,184 · Granted Feb 21, 2023
Base term, 20 years from filing
Today
2014
2034
Clock starts
Mar 11, 2014
Mar 11, 2014
Term ends
Mar 11, 2034
Mar 11, 2034
Granted
Feb 21, 2023
Feb 21, 2023
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,561,560, to Mar 11, 2034. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 11, 2014, when application 14/204,773, the earliest non-provisional in its chain, was filed (this one was filed Aug 17, 2021) | Mar 11, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,561,560) | resolves to Mar 11, 2034, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 11, 2034 | High confidence |
This family
| US 10,561,560 | In force Aug 2035 | Aug 2035 |
| Application 14/587,955 | Abandoned not computed | not computed |
| Application 16/249,829 | Abandoned not computed | not computed |
| Application 16/791,051 | Abandoned not computed | not computed |
| US 11,883,095 | In force Feb 2035 | Feb 2035 |
| US 11,583,462 | this patent Mar 2034 | Mar 2034 |
| US 12,016,803 | In force Mar 2034 | Mar 2034 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 4, 2022 Reel 58891, frame 973 | Boutoussov, Dmitri | Biolase, Inc. | Assignment of Assignor's Interest |
| Feb 4, 2022 Reel 58956, frame 711 | Tuck, David; Celerasys Corp. | Biolase, Inc. | Assignment of Assignor's Interest |
| Dec 17, 2024 Reel 69715, frame 613 | Biolase, Inc.; BL Acquisition Corp.; BL Acquisition II, Inc. | Biolase MG LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2034
Term ends Mar 11, 2034. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,561,560, ends no earlier than this term, so it caps nothing.
Citations
9
later US patents cite this one
That is top 10% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.